SORILUX (Stiefel Laboratories Inc)


Welcome to the PulseAid listing for the SORILUX drug offered from Stiefel Laboratories Inc. This Vitamin D [Chemical/Ingredient],Vitamin D Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Stiefel Laboratories Inc
NON-PROPRIETARY NAME: calcipotriene
SUBSTANCE NAME: CALCIPOTRIENE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Vitamin D [Chemical/Ingredient],Vitamin D Analog [EPC]
ROUTE: TOPICAL
DOSAGE FORM: AEROSOL, FOAM
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-10-26
END MARKETING DATE: 2018-10-31


SORILUX HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSORILUX from Stiefel Laboratories Inc
LABELER NAME: Stiefel Laboratories Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 50(ug/g)
START MARKETING DATE: 2010-10-26
END MARKETING DATE: 2018-10-31
PRODUCT ID: 0145-2130_8469d93a-5a7a-4c39-8127-e822642f3f58
PRODUCT NDC: 0145-2130
APPLICATION NUMBER: NDA022563

Other CALCIPOTRIENE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.Calcipotriene
G&W Laboratories, Inc.Calcipotriene
Glenmark Pharmaceuticals Inc., USACalcipotriene
Glenmark Pharmaceuticals Inc.,USAcalcipotriene
Impax GenericsCalcipotriene
LEO Pharma Inc.Dovonex
Mayne Pharma LLCSORILUX
Physicians Total Care, Inc.Dovonex
Prasco LaboratoriesCalcipotriene
Sandoz Inc.Calcipotriene
Stiefel Laboratories IncSORILUX
Taro Pharmaceuticals U.S.A., Inc.Calcitrene